SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

GA Poland, IG Ovsyannikova, RB Kennedy - The Lancet, 2020 - thelancet.com
Understanding immune responses to severe acute respiratory syndrome coronavirus 2 is
crucial to understanding disease pathogenesis and the usefulness of bridge therapies, such …

Cytokine storm

DC Fajgenbaum, CH June - New England Journal of Medicine, 2020 - Mass Medical Soc
Cytokine Storm Cytokine storm, a life-threatening disorder involving cytokine elevations and
immune-cell hyperactivation, has various causes and is characterized by constitutional …

Natural history of COVID-19 and therapeutic options

P Gautret, M Million, PA Jarrot… - Expert review of …, 2020 - Taylor & Francis
Introduction: COVID-19 presents benign forms in young patients who frequently present with
anosmia. Infants are rarely infected, while severe forms occur in patients over 65 years of …

Autoantibodies against type I IFNs in patients with life-threatening COVID-19

P Bastard, LB Rosen, Q Zhang, E Michailidis… - Science, 2020 - science.org
INTRODUCTION Interindividual clinical variability is vast in humans infected with severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), ranging from silent infection to …

Coronaviruses: innate immunity, inflammasome activation, inflammatory cell death, and cytokines

SJ Lee, R Channappanavar, TD Kanneganti - Trends in immunology, 2020 - cell.com
The innate immune system acts as the first line of defense against pathogens, including
coronaviruses (CoVs). Severe acute respiratory syndrome (SARS)-CoV and Middle East …

The emerging role of vitamin C in the prevention and treatment of COVID-19

AC Carr, S Rowe - Nutrients, 2020 - mdpi.com
Investigation into the role of vitamin C in the prevention and treatment of pneumonia and
sepsis has been underway for many decades. This research has laid a strong foundation for …

The known unknowns of T cell immunity to COVID-19

AC Karlsson, M Humbert, M Buggert - Science Immunology, 2020 - science.org
Tremendous progress has been made in understanding the role of T cell immunity in acute
and convalescent COVID-19 infection. Here, we shed light on the “known unknowns” of …

Type I interferon (IFN)-regulated activation of canonical and non-canonical signaling pathways

C Mazewski, RE Perez, EN Fish… - Frontiers in …, 2020 - frontiersin.org
For several decades there has been accumulating evidence implicating type I interferons
(IFNs) as key elements of the immune response. Therapeutic approaches incorporating …

Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases

R Carsetti, S Zaffina, E Piano Mortari, S Terreri… - Frontiers in …, 2020 - frontiersin.org
SARS-CoV-2 is a novel coronavirus, not encountered before by humans. The wide spectrum
of clinical expression of SARS-CoV-2 illness suggests that individual immune responses to …

Life-threatening COVID-19: defective interferons unleash excessive inflammation

Q Zhang, P Bastard, A Bolze, E Jouanguy, SY Zhang… - Med, 2020 - cell.com
The risk of life-threatening COVID-19 pneumonia increases sharply after 65 years of age,
but other epidemiological risk factors, genetic or otherwise, are modest. Various rare …